Clinical Trial: Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863662) titled 'Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm' on March 03.

Brief Summary: Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of the study is to evaluate efficacy and safety of the Fixed-Dose Combination of Etoricoxib/Tizanidine versus Etoricoxib in Patients With Acute Low Back Pain Associated to muscle spasms.

Study Start Date: Sept. 18, 2024

Study Type: INTERVENTIONAL

Condition: Acute Low-back Pain Muscle Spasm; Back Pain

Intervention: DRUG: Etoricoxib + Tizanidine fixed dose

One sachet with 120 mg / 4 mg, dissolved in 100...